Breaking News

Rentschler Biopharma Celebrates 150th Anniversary

Undertakes the largest expansion in its history and establishes new apprenticeship program.

Rentschler Biopharma, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, is celebrating its 150th anniversary this year, and the company continues to evolve and grow.

Facility Expansion

Adjacent to its existing facility in Milford, MA, the company has undertaken the largest expansion in its long history. The Rentschler Biopharma Manufacturing Center (RBMC) will add 22,000 square feet of manufacturing cleanroom space and house four new 2,000 L single-use bioreactors, in addition to being highly automated and leveraging industry 4.0 solutions. As the company grows in terms of capacity, technology, projects and clients, it is also growing its highly trained workforce.

Training Program

Earlier this year, the company kicked off a new program with MassBioEd and Worcester Polytechnic Institute (WPI) to train people re-joining the workforce for stable, attractive biotech manufacturing opportunities. MassBioEd’s Life Sciences Apprenticeship Program is building talent pipelines for positions like Biomanufacturing Technicians, providing individuals with non-traditional training opportunities to enter careers in the life sciences. Rentschler Biopharma joined as one of the first employer partners for the expansion of the program into Central Massachusetts.
 
The inaugural group of ten (10) apprentices has completed 16 weeks of training: Eight weeks involved a MassBio-led curriculum including basic academic coursework, as well as an introduction to business and to biotech. The additional eight weeks were spent at WPI Biomanufacturing Education and Training Center (BETC) to learn the fundamentals of biotech production, including both upstream and downstream processes. Five of the apprentices started at Rentschler Biopharma in September, and the remaining five at the end of November.
 
Mark Caswell, vice president, site head, Rentschler Biopharma Inc., said: “Rentschler Biopharma has remained relevant throughout its history by creating value sustainably for our employees and clients. We focus on anticipating the needs of tomorrow with highly trained and experienced people. The workforce training program we have undertaken with WPI and MassBioEd is truly a win-win situation, enabling people from underrepresented communities to enter careers in the biotech space while supporting our need to bring in new talent.”

Related News

Rentschler Biopharma recently appointed Christiane Bardroff as chief operating officer (COO), effective December 1, 2022.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters